Evidence map›Paper›PMID 31613024›Full record

ArticleThe EMBO journal2019

The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.

Abhay Narayan Singh, Judith Oehler, Ignacio Torrecilla, Susan Kilgas, Shudong Li, Bruno Vaz, Claire Guérillon, John Fielden, Esperanza Hernandez-Carralero, Elisa Cabrera and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. The E3 Ligase RNF8 Promotes Ubiquitination and Degradation of ChREBPα During Liver Stress Response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Ubiquitin system mutations in neurological diseases.Trends in biochemical sciences · 2024
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 4 countries.

Abhay Narayan SinghDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Judith OehlerDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Ignacio TorrecillaDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Susan KilgasDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Shudong LiDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Bruno VazDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Claire GuérillonNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
John FieldenDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Esperanza Hernandez-CarraleroUnidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Elisa CabreraUnidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Iain Dc TullisDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Mayura MeerangInstitute of Pharmacology and Toxicology-Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Paul R BarberDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Raimundo FreireUnidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Jason ParsonsDepartment of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, UK.
Borivoj VojnovicDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Anne E KiltieDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.ORCID 0000-0001-7208-2912
Niels MailandNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-6623-709X
Kristijan RamadanDepartment of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.ORCID 0000-0001-5522-021X
Cancer Research UK · GBUniversidad de La Laguna · ESUniversity of Copenhagen · DKUniversity of Liverpool · GBUniversity of Zurich · CH

Funding

Cancer Research UK 15677Cancer Research UK 23279Medical Research Council MC_EX_MR/K022830/1Medical Research Council MC_UU_00001/1Medical Research Council MR/M000354/1Swiss National Science Foundation 31003A_141197
6 · The paper itself

Abstract

The E3 ubiquitin ligase RNF8 (RING finger protein 8) is a pivotal enzyme for DNA repair. However, RNF8 hyper-accumulation is tumour-promoting and positively correlates with genome instability, cancer cell invasion, metastasis and poor patient prognosis. Very little is known about the mechanisms regulating RNF8 homeostasis to preserve genome stability. Here, we identify the cellular machinery, composed of the p97/VCP ubiquitin-dependent unfoldase/segregase and the Ataxin 3 (ATX3) deubiquitinase, which together form a physical and functional complex with RNF8 to regulate its proteasome-dependent homeostasis under physiological conditions. Under genotoxic stress, when RNF8 is rapidly recruited to sites of DNA lesions, the p97-ATX3 machinery stimulates the extraction of RNF8 from chromatin to balance DNA repair pathway choice and promote cell survival after ionising radiation (IR). Inactivation of the p97-ATX3 complex affects the non-homologous end joining DNA repair pathway and hypersensitises human cancer cells to IR. We propose that the p97-ATX3 complex is the essential machinery for regulation of RNF8 homeostasis under both physiological and genotoxic conditions and that targeting ATX3 may be a promising strategy to radio-sensitise BRCA-deficient cancers.

Indexed as

DNA Breaks, Double-StrandedDNA RepairHomeostasisAdenosine TriphosphatasesAtaxin-3Cell SurvivalChromatinDNA-Binding ProteinsGenomic InstabilityHEK293 CellsHeLa CellsHumansNuclear ProteinsProteasome Endopeptidase ComplexProteolysisSignal TransductionAdenosine TriphosphatasesAtaxin-3ChromatinDNA-Binding ProteinsNuclear Proteinsp97 ATPaseProteasome Endopeptidase ComplexRNF8 protein, humanUbiquitinUbiquitin-Protein LigasesAtaxin 3DNA double-strand break repairE3 ubiquitin ligase RNF8genome stabilityp97/VCP ATPase

Identifiers

PMID31613024
PMCPMC6826192
OpenAlexW2980745280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.